TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01986595 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01986595 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT00013884 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00096382 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00096382 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05168059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03386708 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00005273 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT02027805 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT02399761 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT04941625 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04941625 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04611672 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00950339 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02120417 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00730236 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT00730236 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00972933 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06765577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02140463 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT02140463 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT02140463 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02764879 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03994094 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00805207 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02410915 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT02858297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01667510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01949701 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01523821 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03054090 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01378182 — Predictive Biomarker (PRD): ATP7B mRNA
Genes: ATP7B; PWD; WC1; WND
Study NCT00255320 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT05937594 — Safety Biomarker (SAF): let-7a
Study NCT05937594 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study NCT05937594 — Safety Biomarker (SAF): miR-192
Genes: MIR192
Study NCT00048880 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02177487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05134337 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02080182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02597790 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT02597790 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00949884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03729102 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02964507 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02964507 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02964507 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03644901 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT02117479 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT01876810 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00491556 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02361346 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01015131 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00004935 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04344041 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04344041 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02211638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04382755 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT00458536 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01515735 — Predictive Biomarker (PRD): LOXL1 mRNA
Genes: LOXL1; LOXL
Study NCT04622072 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04622072 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02254057 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02104739 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02667496 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04166292 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01851096 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01407731 — Predictive Biomarker (PRD): ITSN1 mRNA
Genes: ITSN1; ITSN; SH3D1A
Study NCT04178057 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT03600675 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02812511 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT02673281 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04525131 — Predictive Biomarker (PRD): CPOX mRNA
Genes: CPOX; CPO; CPX
Study NCT01214460 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03540992 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00274430 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT01536821 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT03459040 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01265888 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03732924 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03344835 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02991495 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03786913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01995448 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT01995448 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03381066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01308632 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT01308632 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01308632 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01308632 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02811575 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02811575 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02295566 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02642081 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02544633 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03126864 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02182011 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT02182011 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT02182011 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02181257 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT00787319 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02253251 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03987425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03389360 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01111422 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02640443 — Predictive Biomarker (PRD): PREPL mRNA
Genes: PREPL; KIAA0436
Study NCT00004187 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01508312 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03518710 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02385019 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04358458 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study NCT03646019 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT03486964 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01069575 — Predictive Biomarker (PRD): KIF20A mRNA
Genes: KIF20A; MKLP2; RAB6KIFL
Study NCT01069575 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00042809 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00042809 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03127449 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04586413 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02455115 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03561337 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03561337 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT02699606 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02451956 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02823873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01199094 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02799316 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03779867 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04302025 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04302025 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00409578 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02108457 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02579317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02125994 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03754933 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT04140487 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04036084 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study NCT02954471 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02336347 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02898584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00957957 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02514538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02860793 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT02860793 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03548207 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03644576 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02024737 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05680376 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02550080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT03174288 — Predictive Biomarker (PRD): NR3C2 mRNA
Genes: NR3C2; MCR; MLR
Study NCT00769483 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT00769483 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study NCT00769483 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study NCT00769483 — Predictive Biomarker (PRD): IRS2 mRNA
Genes: IRS2
Study NCT03901963 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03061708 — Predictive Biomarker (PRD): RICTOR mRNA
Genes: RICTOR; KIAA1999
Study NCT03910192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00775567 — Predictive Biomarker (PRD): SLC2A5 mRNA
Genes: SLC2A5; GLUT5
Study NCT01229813 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04007562 — Predictive Biomarker (PRD): LPIN1 mRNA
Genes: LPIN1; KIAA0188
Study NCT02122159 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00475852 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03872778 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT03068962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04252859 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04252859 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02795988 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04077723 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01032681 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04634032 — Predictive Biomarker (PRD): GATA6 mRNA
Genes: GATA6
Study NCT04634032 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT04634032 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TBX3 mRNA
Genes: TBX3
Study NCT02727686 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02048748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05015387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT02382471 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02382471 — Safety Biomarker (SAF): BDNF
Study NCT01605565 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02406664 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00358163 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04408456 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT03567161 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03046914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT03724747 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00565370 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00565370 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04174742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04132739 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02346981 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05484596 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03809013 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00900796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02427906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03100253 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03100253 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04273945 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04583878 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05293418 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03800810 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02951273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04077255 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00396396 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00904254 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03103399 — Predictive Biomarker (PRD): NEB mRNA
Genes: NEB
Study NCT04400695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00065559 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00000495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01489059 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT04235647 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06303414 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01606462 — Predictive Biomarker (PRD): OXTR mRNA
Genes: OXTR
Study NCT00139204 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00926289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02734615 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01906281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01071070 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT01071070 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03281824 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04616586 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00756028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03763656 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04447833 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01068470 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00035893 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03876587 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00328237 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study NCT02589769 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02777775 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00308373 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01939262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02436369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03242382 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04609826 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT01853631 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01853631 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01853631 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT02078973 — Predictive Biomarker (PRD): AVPR2 mRNA
Genes: AVPR2; ADHR; DIR; DIR3; V2R
Study NCT04035486 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04035486 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03671265 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02818426 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02743923 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01867554 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT00704080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02391805 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04161638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02651610 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00986960 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03618966 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00001747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005896 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03702920 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00600002 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04262960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03340298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02654925 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02522299 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT02522299 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02904226 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT03455946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00912418 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05078814 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT00768560 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02473406 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00699790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT03505320 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT03529344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02058810 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04879836 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00394316 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00676416 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT00332631 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02101320 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT03624270 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT04401059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01933815 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT01230216 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01495026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01627704 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03736044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03736044 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04393805 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03749421 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00478907 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36